UK's EU Presidency: Health Priorities

30 December 1997

Public health is a relatively new area of competence for the EuropeanUnion, but action in this field is critical, according to UK Minister for Public Health Tessa Jowell.

The UK Presidency's main priority will be to demonstrate the "practical relevance" of the EU in promoting better health across the Union, and it would make every effort to develop a set of principles which will determine the Health Council's approach to public health in the medium term, she told the Presidency's official launch.

The Health Council meeting on April 30 will focus on the EU Commission's proposed programs on rare diseases, injury prevention and pollution-related illnesses, and EU public health action after 2001. Ms Jowell hoped a recommendation would be adopted on blood safety, and work completed with the European parliament on the proposed network to monitor communicable diseases. "We will keep under review public health issues relating to Transmissible Spongiform Encepalopathies and food law, " she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight